NASDAQ:AMRN
Amarin Corporation PLC Stock News
$0.88
+0.0171 (+1.98%)
At Close: May 09, 2024
Amarin Reports Mixed Q2 As COVID-19 Weighs On Results; Analyst Sees Favorable Risk-Reward
06:10pm, Tuesday, 04'th Aug 2020
Amarin Corporation plc (NASDAQ: AMRN) shares were advancing strongly Tuesday following the release Tuesday of second-quarter results. What Happened: Amarin reported second-quarter revenue of $135.3 m
Coronavirus update: U.S. case tally at 4.72 million and New Jersey, Massachusetts and Connecticut see infections climb again
03:18pm, Tuesday, 04'th Aug 2020
The U.S. case tally for the coronavirus illness COVID-19 rose by fewer than 50,000 on Monday for a second straight day, data aggregated by Johns Hopkins...
Amarin's Vascepa Sales Jump 34% in Q2 Despite COVID-19 Headwinds
03:16pm, Tuesday, 04'th Aug 2020
The big wild card for the company now is its appeal of a court ruling invalidating key patents for the high triglyceride drug.
U.S. government begins two trials testing Eli Lilly's coronavirus antibody drug
03:00pm, Tuesday, 04'th Aug 2020
The trials, called ACTIV-2 and ACTIV-3, will look at U.S. drugmaker Eli Lilly's experimental treatment known as LY-CoV555, which is being developed in partnership with Canadian biotech AbCellera.
Amarin Announces Plans to Maximize Blockbuster Potential of VASCEPA® (icosapent ethyl) in Europe
02:38pm, Tuesday, 04'th Aug 2020
Amarin to Build Dedicated Organization to Retain Substantial Value of One of the Most Anticipated Cardiovascular Drug Products in Decades Veteran Cardiovascular Commercial Executive Hired to Lead Foc
Amarin (AMRN) maintains revenue growth despite COVID-19 headwinds | AlphaStreet
01:11pm, Tuesday, 04'th Aug 2020
Amarin Corporation plc (NASDAQ:AMRN) reported second quarter 2020 earnings results today.
Abiomed's stock rises on second COVID-19-related EUA for heart pump
11:48am, Tuesday, 04'th Aug 2020
Shares of Abiomed Inc. undefined rallied 2.0% in premarket trading on Tuesday after the company said its Impella heart pump had received an emergency use...
Recap: Amarin Q2 Earnings
11:20am, Tuesday, 04'th Aug 2020
Shares of Amarin Corp (NASDAQ:AMRN) rose 2.2% in pre-market trading after the company reported Q2 results.Quarterly Results Earnings per share were up 200.00% over the past year to $0.01, which beat t
Amarin Reports Second Quarter 2020 Financial Results and Provides Update on Operations
10:00am, Tuesday, 04'th Aug 2020
Total Revenue Increased 34% in Second Quarter 2020 Compared to Second Quarter 2019 Despite COVID-19 HeadwindsMultiple Upcoming Milestones Regarding VASCEPA® Opportunity in United States and Internat
Easterly Government Properties Reports Second Quarter 2020 Results
12:00am, Tuesday, 04'th Aug 2020
Easterly Government Properties, Inc. (NYSE: DEA) (the “Company” or “Easterly”), a fully integrated real estate investment trust (“REIT”) focused prima
GW Pharma's stock rallies after its cannabinoid drug gets a new FDA approval
06:05pm, Monday, 03'rd Aug 2020
Shares of GW Pharmaceuticals undefined rallied 5.0% in trading on Monday after the drugmaker said its cannabinoid drug Epidiolex had received approval from...
We Could Know if Moderna’s Covid-19 Vaccine Works by Halloween, Analyst Says
03:03pm, Monday, 03'rd Aug 2020
Jefferies analyst estimates the biotech’s Phase 3 trial has a 65% chance of working.
WSJ News Exclusive | FDA’s Shifting Standards for Chinese Face Masks Fuel Confusion
01:09pm, Monday, 03'rd Aug 2020
A Food and Drug Administration effort to address a mask shortage has opened the floodgates to Chinese manufacturers selling products of widely varying quality, potentially putting the public at risk a
TikTok, SpaceX and the Allure of Private Companies
12:08pm, Monday, 03'rd Aug 2020
Microsoft confirms TikTok talks, coronavirus is now widespread in both urban and rural areas, Biden VP pick pushed back, and other news to start your day.
AP FACT CHECK: Trump hype on drug costs, hydroxychloroquine
04:07am, Monday, 03'rd Aug 2020
President Donald Trump is making grandiose claims about slashing drug prices and the efficacy of a treatment for COVID-19 that don't hold up to reality
